DaVita has committed to meet minimum required purchasing volumes of Amgen’s kidney drugs Epogen and Aranesp. In return, the company will receive discounted pricing and rebates on the drugs.
The deal replaces prior agreements between the two parties set to expire in 2018.
More articles on supply chain:
Judge orders Sanofi, Regeneron’s cholesterol drug off the market following patent dispute
10 medical device trends for 2017
Director of supply chain named one of best jobs in America by CNNMoney
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
